Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment

The exploratory analysis included 13 patients and found improved gas transfer, quality of life and surfactant burden with daily molgramostim.

Summary by Rutland Herald
YARDLEY, Pa.--(BUSINESS WIRE)--Oct 21, 2026-

3 Articles

Rutland HeraldRutland Herald
+2 Reposted by 2 other sources
Center

Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment

YARDLEY, Pa.--(BUSINESS WIRE)--Oct 21, 2026-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Rutland Herald broke the news on Wednesday, October 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Yardley icon

Yardley

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal